Medicenna Therapeutics Corp T.MDNA

Alternate Symbol(s): MDNAF

Healthcare Biotechnology

Medicenna Therapeutics Corp. is a Canada-based clinical-stage immunotherapy company. The Company is focused on the development of selective versions of interleukin-2 (IL-2), interleukin-4 (IL-4) and interleukin-13 (IL-13) Superkines and Empowered Superkines for the treatment of cancer, inflammation and immune-mediated diseases. Its long-acting IL-2 Superkine, MDNA11, is an IL-2 with superior CD122 (IL-2 receptor beta) binding without CD25 (IL-2 receptor alpha) affinity, thereby preferentially stimulating cancer-killing effector T cells and NK cells. The Company’s IL-4 Empowered Superkine, bizaxofusp, has been studied in five clinical trials including a Phase IIb trial for recurrent glioblastoma (GBM). The Company’s early-stage Bifunctional SuperKine ImmunoTherapies (BiSKITs) program is designed to enhance the ability of Superkines to treat immunologically cold tumors.

TSX:MDNA - Post by User

Medicenna Therapeutics Corp > Surprised and grateful that MDNA ran up over 2.00

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Apr 27, 2024 9:25pm

81 Views

Post# 36011299

RE:RE:RE:Surprised and grateful that MDNA ran up over 2.00

Beware of this pump and dump.....Enemememem is nothing but a paid shill .....he's over on the ONCY board constantly trashing other posters while his employer shorts the stock....he's pumping here now, so take your profits while you can, because once they're done pumping, they'll short this stock too and leave investors hanging.....don't believe me?....go check out this A-whole's posts over on the ONCY board.

<< Previous

Bullboard Posts

Next >>

Nord Precious Metals reveals silver zone at Castle East